Search Within

HODGKIN LYMPHOMA

Antagonists of Growth Hormone-Releasing Hormone in Oncology

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 9,Issue: 3
Page: 163-170
Authors: Andrew V. Schally and Jozsef L. Varga

Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 15-34
Authors: Tadeusz Robak, Agnieszka Wierzbowska and Ewa Robak

Highly Active Antiretroviral Therapy is Associated with Improved Survival among Patients with AIDS-Related Primary Central Nervous System Non-Hodgkins Lymphoma

Journal: Current HIV Research
Volume: 4,Issue: 3
Page: 375-378
Authors: Catherine Diamond, Thomas H. Taylor, Theresa Im, Mohammed Miradi, Mark Wallace and Hoda Anton-Culver

Radioimmunotherapy of Non-Hodgkins Lymphomas

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1293-1300
Authors: Bruce D. Cheson

Immunotoxins in the Treatment of Hematologic Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1301-1311
Authors: Robert J. Kreitman and Ira Pastan

Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1329-1334
Authors: Cornelius Miething, Christian Peschel and Justus Duyster

Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 26
Page: 3165-3189
Authors: Tadeusz Robak, Ewa Lech-Maranda, Anna Korycka and Ewa Robak

Radionuclide Therapy of Cancer with Radiolabeled Antibodies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 335-343
Authors: Wim J. Oyen, E. J. Postema, Frans H. Corstens, Otto C. Boerman and Manuel J. Koppe

Interferon: Cellular Executioner or White Knight?

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 12
Page: 1279-1289
Authors: S. G. Maher, A. L. Romero-Weaver, A. J. Scarzello and A. M. Gamero

Relation Between Helicobacter Pylori Infection and Gastroduodenal Diseases

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 109-115
Authors: Antonio De Luca, Elisabetta Buommino, Lucrezia Manente and Maria A. Tufano

Genetic Idiotypic and Tumor Cell-Based Vaccine Strategies for Indolent Non Hodgkins Lymphoma

Journal: Current Gene Therapy
Volume: 5,Issue: 5
Page: 511-521
Authors: Pier A. Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, Salvatore Siena and Alessandro M. Gianni

Angiogenesis in Lymphoma: A Short Review

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 609-613
Authors: Anas Younes

EBV-Associated Tumors: Pathogenetic Insights for Improved Disease Monitoring and Treatment

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 1
Page: 27-44
Authors: Riccardo Dolcetti, Massimo Guidoboni, Annunziata Gloghini and Antonino Carbone

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 4,Issue: 4
Page: 221-238
Authors: Christine A. White

Non-Hodgkins Lymphoma: Review of Conventional Treatments

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 279-291
Authors: P. Multani, C.A. White and A. Grillo-Lopez

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 301-311
Authors: A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White

Radioimmunotherapy of B-Cell NHL

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 327-339
Authors: R.F. Meredith and S.J. Knox

Molecular Analysis of Primary Central Nervous System and Primary Intraocular Lymphomas.

Journal: Current Molecular Medicine
Volume: 1,Issue: 2
Page: 259-272
Authors: N. Tuaillon and C. C. Chan

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 1
Page: 1-9
Authors: A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 4
Page: 303-312
Authors: Christine A. White, Judy R. Berlfein and Antonio J. Grillo-Lopez

Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 6
Page: 373-381
Authors: Bjorn Tore Gjertsen, Therese Bredholt, Nina Anensen and Olav Karsten Vintermyr

NBS1 Heterozygosity and Cancer Risk

Journal: Current Genomics
Volume: 9,Issue: 4
Page: 275-281
Authors: Alessandra di Masi and Antonio Antoccia

Polymorphisms of Human N-Acetyltransferases and Cancer Risk

Journal: Current Drug Metabolism
Volume: 9,Issue: 6
Page: 520-531
Authors: Jose A.G Agundez

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2051-2060
Authors: M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps

Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo

Journal: Current Drug Targets
Volume: 10,Issue: 2
Page: 110-117
Authors: B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop

Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 9
Page: 966-982
Authors: J. Harvey Turner

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman

Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?

Journal: Current Drug Targets
Volume: 11,Issue: 2
Page: 179-186
Authors: P. L. Lakatos and P. Miheller

Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 2
Page: 74-81
Authors: Luca Arcaini and Raffaele Bruno

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 790-800
Authors: Aude-Helene Capietto, Samarh Keirallah, Emilie Gross, Nicolas Dauguet, Emilie Laprevotte, Christine Jean, Julie Gertner-Dardenne, Christine Bezombes, Anne Quillet-Mary, Mary Poupot, Loic Ysebaert, Guy Laurent and Jean-Jacques Fournie

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

Radioimmunotherapy of Solid Tumors: Searching for the Right Target

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 26-44
Authors: Hong Song and George Sgouros

Notch and NF-κB Signaling Pathways in the Biology of Classical Hodgkin Lymphoma

Journal: Current Molecular Medicine
Volume: 11,Issue: 3
Page: 236-245
Authors: R. Schwarzer and F. Jundt

Antiangiogenic Therapies in Non-Hodgkin's Lymphoma

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1030-1043
Authors: J. Ruan

Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 41-51
Authors: Erin Reid, Ajay Nooka, Jawaunna Blackmon and Mary Jo Lechowicz

mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 7
Page: 945-954
Authors: A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta and G. Ranieri

Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 9
Page: 976-983
Authors: Anna Korycka, Jerzy Z. Blonski and Tadeusz Robak

Use of Radioimmunotherapy in Stem Cell Transplantation and Posttransplantation: Focus on Yttrium 90 Ibritumomab Tiuxetan

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 3
Page: 239-248
Authors: Arturo Molina, Amrita Krishnan, Henry Fung, Ian W. Flinn, David Inwards, Jane N. Winter and Auayporn Nademanee

Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 9
Page: 805-824
Authors: Erik De Clercq

Gallium in Cancer Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 15
Page: 1575-1583
Authors: Michael A. Jakupec and Bernhard K. Keppler

dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention

Journal: Current Protein & Peptide Science
Volume: 2,Issue: 4
Page: 349-360
Authors: Friedrich A. Grasser, Bernd F.M. Romeike, Gerald Niedobitek, John Nicholls and Elisabeth Kremmer

Malignancy Risk in Systemic Lupus: Recent Research and Ongoing Challenges

Journal: Current Rheumatology Reviews
Volume: 4,Issue: 1
Page: 59-62
Authors: Sasha Bernatsky, Rosalind Ramsey-Goldman and Ann E. Clarke

The Role of Major Histocompatibility Complex Polymorphisms in the Incidence and Outcome of Non-Hodgkin Lymphoma

Journal: Current Immunology Reviews
Volume: 5,Issue: 4
Page: 300-310
Authors: Jacek Nowak, Przemyslaw Juszczynski and Krzysztof Warzocha

Proteomic Analysis of Mitochondria in Raji Cells Following Exposure to Radiation: Implications for Radiotherapy Response

Journal: Protein & Peptide Letters
Volume: 16,Issue: 11
Page: 1350-1359
Authors: Yujie Jiang, Xin Liu, Xiaosheng Fang and Xin Wang

Diffuse Large B-Cell Lymphoma Presenting as an Anterior Chest Wall Mass: A Case Report and Literature Review

Journal: Current Respiratory Medicine Reviews
Volume: 5,Issue: 4
Page: 239-241
Authors: Chrissy A. Navejar and Michael J. Morris

B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 11,Issue: 2
Page: 99-111
Authors: Mario Salvi, Guia Vannucchi and Paolo Beck-Peccoz

Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma

Journal: Current HIV Research
Volume: 2,Issue: 3
Page: 215-221
Authors: Deirdre Killebrew and Bruce Shiramizu

Viral and Cellular Cytokines as Therapeutic Targets in AIDS-Related Lymphoproliferative Disorders

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3,Issue: 1
Page: 81-96
Authors: Yoshiyasu Aoki and Giovanna Tosato

Impact of PET on the Radiation Treatment of Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 2,Issue: 3
Page: 169-174
Authors: Annibale Versari, Cinzia Iotti and Francesco Merli

Hodgkin Lymphoma in HIV Positive Patients

Journal: Current HIV Research
Volume: 8,Issue: 2
Page: 141-146
Authors: Nicolas Mounier, Michele Spina and Jean P. Spano

Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice

Journal: Current HIV Research
Volume: 8,Issue: 6
Page: 482-486
Authors: Miguel Genebat, Ezequiel Ruiz-Mateos, Ildefonso Pulido, Alejandro Gonzalez-Serna, Antonio Garcia-Perganeda, Gema Mendez, Maria Concepcion Romero-Sanchez, Sara Ferrando-Martinez and Manuel Leal

The Impact of HAART on HPV-Related Cervical Disease

Journal: Current HIV Research
Volume: 8,Issue: 7
Page: 493-497
Authors: David H. Adler

Novel and Emerging Drugs for Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 522-530
Authors: E. M. Stein and M. S. Tallman

Heat Shock Proteins (HSPs) Based Anti-Cancer Vaccines

Journal: Current Molecular Medicine
Volume: 12,Issue: 9
Page: 1183-1197
Authors: D.R. Ciocca, N. Cayado-Gutierrez, M. Maccioni and F.D. Cuello-Carrion

Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 65-69
Authors: Kathy J. Helzlsouer and Lisa Gallicchio

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 1
Page: 20-27
Authors: Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle

TP73, An Under-Appreciated Player in Non-Hodgkin Lymphoma Pathogenesis and Management

Journal: Current Molecular Medicine
Volume: 14,Issue: 4
Page: 432-439
Authors: H.M. Hassan, B.J. Dave and R.K. Singh

Composite Lymphomas: A Challenging Entity

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 2
Page: 80-89
Authors: Sotirios Sachanas, Gerassimos A. Pangalis, Christina Kalpadakis, Xanthi Yiakoumis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Flora Kontopidou, Styliani Kokoris, Marina Siakantaris, Nora-Athina Viniou, Pinelopi Korkolopoulou, Helen Papadaki, Panayiotis Panayiotidis and Maria Angelopoulou

Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 281-295
Authors: Elizabeth F. Krakow, Hui-Sheng Ai, Brian Shaffer, Jean-Sebastien Delisle, Kai-Xun Hu and Anthony D. Sung

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges

Journal: Current Drug Targets
Volume: 18,Issue: 7
Page: 766-771
Authors: Sabino Russi, Loredana Sansonno and Domenico Sansonno*

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 2
Page: 160-168
Authors: Parul Thakral, Suhas Singla, Atul Vashist, Madhav P. Yadav, Santosh K. Gupta, Jaya S. Tyagi, Atul Sharma, Chandra S. Bal, Snehlata and Arun Malhotra

Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance

Journal: Current Rheumatology Reviews
Volume: 14,Issue: 2
Page: 131-139
Authors: Rossella Talotta*, Fabiola Atzeni, Alberto Batticciotto, Maurizio Benucci, Sara Bongiovanni and Piercarlo Sarzi-Puttini

Analysis of Metabolic Parameters Coming from Basal and Interim PET in Hodgkin Lymphoma

Journal: Current Medical Imaging Reviews
Volume: 14,Issue: 4
Page: 533-544
Authors: Davide D`Urso, Alessandro Stefano, Alessandra Romano, Giorgio Russo*, Sebastiano Cosentino, Federico Fallanca, Mauro Gioe, Massimo Attanasio, Maria Gabriella Sabini, Francesco Di Raimondo and Massimo Ippolito

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18,Issue:
Page: 1-28
Authors: Ota Fuchs*